循環器内科 Twitter アカウントlanguage English

英文原著論文 "2018" Original Papers in English

緑色のタイトル部分をクリックすると、論文PDFが表示されます。

【 2018 年 】（IF: 2017 年）

  1. Eguchi K, Shindo T, Ito K, Ogata T, Kurosawa R, Kagaya Y, Monma Y, Ichijo S, Kasukabe S, Miyata S, Yoshikawa T, Yanai K, Taki H, Kanai H, Osumi N, Shimokawa H. Whole-brain low-intensity pulsed ultrasound therapy markedly improves cognitive dysfunctions in mouse models of dementia-Crucial roles of endothelial nitric oxide synthase- Brain Stim. 11:959-973,2018. (IF=6.120) (プレスリリース、6月19日)

  2. Hirano M, Yamamoto H, Hasebe Y, Fukuda K, Morosawa S, Amamizu H, Ohyama K, Uzuka H, Takayama K, Shimokawa H. Development of a novel shock wave catheter ablation system -A validation study in pigs in vivo- Europace. 20:1856-1865,2018. doi: 10.1093/europace/eux244 (IF=4.521) (プレスリリース、2017年8月3日)

  3. Kagaya Y, Ito K, Takahashi J, Matsumoto Y, Takashi Shiroto T, Tsuburaya R, Kikuchi Y, Hao K, Nishimiya K, Shindo T, Ogata T, Kurosawa R, Eguchi K, Monma Y, Ichijo S, Hatanaka K, Miyata S, Shimokawa H. Low-energy cardiac shock wave therapy to suppress left ventricular remodeling in patients with acute myocardial infarction. -A first-in-human study- Coron Art Dis. 29:294-300,2018. (IF=1.705)

  4. Kasahara S, Sakata Y, Nochioka K, Yamauchi T, Onose T, Tsuji K, Abe R, Oikawa T, Sato M, Aoyanagi H, Miura M, Shiroto T, Takahashi J, Miyata S, Shimokawa H; CHART-2 Investigators. Comparable prognostic impact of BNP levels among HFpEF, Borderline HFpEF and HFrEF: a report from the CHART-2 Study. Heart Vessels. 33:997-1007,2018. (IF=2.185)

  5. Kato K, Kakisaka Y, Jin K, Fujikawa M, Nakamura M, Suzuki N, Kondo M, Fukuda K, Shimokawa H, Nakasato N. Stressful medical explanation may cause syncope in patients with emotion-triggered neurocardiogenic syncope. Pacing Clin Electrophysiol. 41:96-98,2018. (IF=1.441)

  6. Kikuchi N, Satoh K, Kurosawa R, Yaoita N, Elias-Al-Mamun M, Siddique MHA, Omura J, Satoh T, Nogi M, Sunamura S, Miyata S, Saito Y, Hoshikawa Y, Okada Y, Shimokawa H. Selenoprotein P promotes the development of pulmonary arterial hypertension -A possible novel therapeutic target- Circulation. 138:600-623,2018. (IF=18.880) (プレスリリース、5月18日)

  7. Kikuchi Y, Ito K, Shindo T, Hao K, Shiroto T, Matsumoto Y, Takahashi J, Matsubara T, Yamada A, Ozaki Y, Hiroe M, Misumi K, Ota H, Takanami K, Hiraide T, Takase K, Tanji F, Tomata Y, Tsuji I, Shimokawa H. A multicenter trial of extracorporeal cardiac shock wave therapy for refractory angina pectoris-Report of the highly advanced medical treatment in Japan- Heart & Vessels. doi: 10.1007/s00380-018-1215-4. (IF=2.185)

  8. Kimura Y, Fukuda K, Nakano M, Hasebe Y, Fukasawa K, Chiba T, Miki K, Tatebe S, Miyata S, Ota H, Kimura M, Adachi O, Saiki Y, Shimokawa H. Prognostic significance of PR interval prolongation in adult patients with total correction of Tetralogy of Fallot. Circ Arrhythm Electrophysiol. 2018;11:e006234. DOI: 10.1161/CIRCEP.118.006234 (IF=4.712)

  9. Kojima S, Ogawa H, Kimura K, Takayama M, Sumiyoshi T, Yasuda S, Takahashi J, Shimokawa H, Nishihira K, Nakao YM, Honda S, Takegami M. Nationwide real-world database of 20,462 patients enrolled in the Japanese Acute Myocardial Infarction Registry (JAMIR): impact of emergency coronary intervention in a super-aging population. IJC Heart & Vasculature. 20:1-6,2018. (IF=2.185)

  10. Konno R, Tatebe S, Sugimura K, Satoh K, Aoki T, Miura M, Yamamoto S, Sato H, Kozu K, Terui Y, Miyata S, Adachi O, Kimura M, Saiki Y, Shimokawa H. Effects of hepatitis C virus antibody-positivity on cardiac function and long-term prognosis in patients with adult congenital heart disease. Am J Cardiol. 122:1965-1971,2018. (IF=3.171)

  11. Kotooka N, Kitakaze M, Nagashima K, Asaka M, Kinugasa Y, Nochioka K, Mizuno A, Nagatomo D, Mine D, Yamada Y, Kuratomi A, Okada N, Fujimatsu D, Kuwahata S, Toyoda S, Hirotani SI, Komori T, Eguchi K, Kario K, Inomata T, Sugi K, Yamamoto K, Tsutsui H, Masuyama T, Shimokawa H, Momomura SI, Seino Y, Sato Y, Inoue T, Node K; HOMES-HF study investigators. The first multicenter, randomized, controlled trial of home telemonitoring for Japanese patients with heart failure: home telemonitoring study for patients with heart failure (HOMES-HF). Heart Vessels. 33:866-876,2018. (IF=2.185)

  12. Kozu K, Sugimura K, Aoki T, Tatebe S, Yamamoto S, Yaoita N, Shimizu T, Nochioka K, Sato H, Konno R, Satoh K, Miyata S, Shimokawa H. Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension. Heart Vessels. 33:939-947,2018. (IF=2.185)

  13. Matsumoto M, Asaumi Y, Nakamura Y, Nakatani T, Nagai T, Kanaya T, Kawakami S, Honda S, Kataoka Y, Nakajima S, Seguchi O, Yanase M, Nishimura K, Miyamoto Y, Kusano K, Anzai T, Noguchi T, Fujita T, Kobayashi J, Ishibashi-Ueda H, Shimokawa H, Yasuda S. Clinical determinants of successful weaning from extracorporeal membrane oxygenation in patients with fulminant myocarditis. ESC Heart Fail. 5:675-684,2018.

  14. Miyauchi K, Kimura T, Shimokawa H, Daida H, Iimuro S, Iwata H, Ozaki Y, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Fukumoto Y, Hokimoto S, Ohashi Y, Ohtsu H, Saito Y, Matsuzaki M, Nagai R, for the REAL-CAD Trial Investigaters. Rationale and design of randomized evaluation of aggressive or moderate lipid lowering therapy with pitavastatin in coronary artery disease (REAL-CAD) Trial. Int Heart J. 59:315-320,2018. (IF=1.826)

  15. Nihei T, Takahashi J, Hao K, Kikuchi Y, Odaka Y, Tsuburaya R, Nishimiya K, Matsumoto Y, Ito K, Miyata S, Sakata Y, Shimokawa H. Prognostic impacts of Rho-kinase activity in circulating leukocytes in patients with vasospastic angina. Eur Heart J. 39:952-959,2018. (IF=23.425) (プレスリリース、11月20日)

  16. Nishimiya K, Matsumoto Y, Wang H, Piao Z, Ohyama K, Uzuka H, Hao K, Tsuburaya R, Takahashi J, Ito K, Shimokawa H. Absence of adventitial vasa vasorum formation at the coronary segment with myocardial bridge -An optical coherence tomography study- Int J Cardiol. 250:275-277,2018. (IF=4.034)

  17. Nogi M, Satoh K, Sunamura S, Kikuchi N, Satoh T, Kurosawa R, Omura J, Elias Al-Mamun M, Siddique MAH, Numano K, Kudo S, Miyata S, Akiyama M, Kumagai K, Kawamoto S, Saiki Y, Shimokawa H. SmgGDS prevents thoracic aortic aneurysm formation and rupture by phenotypic preservation of aortic smooth muscle cells. Circulation. 138(21):2413-2433,2018. (IF=18.880) (プレスリリース、6月26日)

  18. Ogoshi T, Tsutsui M, Kido T, Sakanashi M, Naito K, Oda K, Ishimoto H, Yamada S, Wang K-Y, Toyohira Y, Izumi H, Masuzaki H, Shimokawa H, Yanagihara N, Yatera K, Mukae H. Protective role of myelocytic nitric oxide synthases against hypoxic pulmonary hypertension in mice. Am J Resp Crit Care Med. 198:232-244,2018. (IF=15.239)

  19. Ong P, Camici PG, Beltrame J, Crea F, Shimokawa H, Sechtem U, Kaski JC, Bairey Merz CN; Coronary Vasomotion Disorders International Study Group (COVADIS). International standardization of diagnostic criteria for microvascular angina. Int J Cardiol. 250:16-20,2018. (IF=4.034)

  20. Ohyama K, Matsumoto Y, Takanami K, Ota H, Nishimiya K, Sugisawa J, Tsuchiya S, Amamizu H, Uzuka H, Suda A, Shindo T, Kikuchi Y, Hao K, Tsuburaya R, Takahashi J, Miyata S, Sakata Y, Takase K, Shimokawa H. Coronary adventitial and perivascular adipose tissue inflammation in patients with vasospastic angina. J Am Coll Cardiol. 71:414-425,2018. (IF=16.834) (プレスリリース、1月23日)

  21. Ridker PM, Libby P, MacFadyen JG, Thuren T, Ballantyne C, Fonseca F, Koenig W, Shimokawa H, Everett BM, Glynn RJ; CANTOS Trial Group. Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS). Eur Heart J. 39:3499-3507,2018. (IF=23.425)

  22. Ridker PM, MacFadyen JG, Everett BM, Libby P, Thuren T, Glynn RJ; CANTOS Trial Group (Shimokawa H). Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet. 391(10118):319-328,2018. (IF=53.254)

  23. Sakata Y, Miyata S, Nochioka K, Miura M, Shiroto T, Shimokawa H. Sex differences in patients with chronic heart failure with reference to left ventricular ejection fraction -A report from the CHART-2 Study- Gender and Genome. 2: 27-42, 2018.

  24. Saito H, Godo S, Sato S, Ito A, Ikumi Y, Tanaka S, Ida T, Fujii S, Akaike T, Shimokawa H. Important role of endothelial caveolin-1 in the protective role of endothelium-dependent hyperpolarization against nitic oxide-mediated nitrative stress in microcirculation in mice. J Cardiovasc Pharmacol. 71:113-126,2018. (IF=2.227)

  25. Shimokawa H, Yamashita T, Uchiyama S, Kitazono T, Shimizu W, Ikeda T, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Sakuma I, Saku K, Okumura Y, Nakamura Y, Morimoto H, Matsumoto N, Tsuchida A, Ako J, Sugishita N, Shimizu S, Atarashi H, Inoue H. The EXPAND Study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation. Int J Cardiol. 258:126-132,2018. (IF=4.034)

  26. Sunamura S, Satoh K, Kurosawa R, Ohtsuki T, Kikuchi N, Elias-Al-Mamun M, Shimizu T, Ikeda S, Suzuki K, Satoh T, Omura J, Nogi M, Numano K, Siddique MAH, Miyata S, Miura M, Shimokawa H. Different roles of myocardial ROCK1 and ROCK2 in cardiac dysfunction and post-capillary pulmonary hypertension in mice. Proc Nat’l Acad Sci USA. 115:E7129-E7138,2018. (IF=9.504) (プレスリリース、7月10日)

  27. Suzuki H, Matsumoto Y, Ota H, Sugimura K, Takahashi J, Ito K, Miyata S, Fukumoto Y, Taki Y, Shimokawa H. Structural brain abnormalities and cardiac dysfunction in patients with chronic heart failure. Eur J Heart Fail. 20:936-938,2018. (IF=10.683)

  28. Taguchi I, Iimuro S, Iwata H, Takashima H, Abe M, Amiya E, Ogawa T, Ozaki Y, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Fukumoto Y, Hokimoto S, Miyauchi K, Yamazaki T, Ito H, Otsuji Y, Kimura K, Takahashi J, Hirayama A, Yokoi H, Kitagawa K, Urabe T, Okada Y, Terayama Y, Toyoda K, Nagao T, Matsumoto M, Ohashi Y, Kaneko T, Fujita R, Ohtsu H, Ogawa H, Daida H, Shimokawa H, Saito Y, Kimura T, Inoue T, Matsuzaki M, Nagai R, for the REAL-CAD study Investigators. High-dose versus low-dose pitavastatin in Japanese patients with stable coronary artery disease (REAL-CAD): a randomized superiority trial. Circulation. 137:1997-2009,2018. (IF=18.880)

  29. Tanaka S, Shiroto T, Godo S, Saito H, Ikumi Y, Ito A, Sato S, Kajitani S, Shimokawa H. Important role of endothelium-dependent hyperpolarization in pulmonary microcirculation in male mice -Implications for hypoxia-induced pulmonary hypertension- Am J Physiol. 314:H940-H953,2018. (IF=3.077)

  30. Uchiyama S, Atarashi H, Inoue H, Kitazono T, Yamashita T, Shimizu W, Ikeda T, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Shimokawa H. Primary and secondary prevention of stroke and systemic embolism with rivaroxaban in patients with non-valvular atrial fibrillation -Sub-analysis of the EXPAND Study- Heart Vessels. doi:10.1007/s00380-018-1219-0 (IF=2.185)

  31. Yada T, Shimokawa H, Tachibana H. Endothelium- dependent hyperpolarization-mediated vasodilatation compensates nitric oxide-mediated endothelial dysfunction during ischemia in diabetes-induced canine coronary collateral microcirculation in vivo. Microcirculation. 25:e12456,2018. (IF=2.797)